MedWatch

Nordnet economist: Investors doubt future GN growth

Investors have lost short-term faith in GN, says Nordnet investment economist Per Hansen.

Photo: GN Store Nord / PR

When it comes to its stock value, GN Group has not managed to shake off the worst of the corona crisis, says Per Hansen, investment economist at Nordnet.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs